Healthcare -
Biotechnology - NASDAQ - US
$ 0.91
9 %
$ 49.6 M
Market Cap
11.38
P/E
SPRO - ACCOUNTS PAYABLE
Accounts Payable SPRO - Spero Therapeutics, Inc.
1.38 M
LAST VALUE
11.87%
2 YEAR CAGR
-17.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR